Advertisement
Screener

Portola Pharmaceuticals, Inc. Stock-Based Compensation

Portola Pharmaceuticals, Inc. Stock-Based Compensation

Portola Pharmaceuticals, Inc. reported Stock-Based Compensation of $9.48 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2020-05-11

  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2020-03-31 was $9.48M, a 47.02% decline year-over-year.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-12-31 was $10.88M, a 44.97% decline year-over-year.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-09-30 was $11.05M, a 3.05% decline year-over-year.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2019-06-30 was $12.25M, a 7.27% decline year-over-year.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $52.08M, a 5.93% decline from fiscal 2018.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $55.36M, a 27.90% increase from fiscal 2017.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $43.28M, a 42.56% increase from fiscal 2016.
  • Portola Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $30.36M, a 32.83% increase from fiscal 2015.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2020-03-31$9.48M
10-Q · filed 2020-05-11
$20.36M
derived: sum of 2 quarters · filed 2020-05-11
$31.41M
derived: sum of 3 quarters · filed 2020-05-11
$43.66M
derived: sum of 4 quarters · filed 2020-05-11
2019-12-31$10.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$21.93M
derived: sum of 2 quarters · filed 2020-02-28
$34.18M
derived: sum of 3 quarters · filed 2020-02-28
$52.08M
10-K · filed 2020-02-28
2019-09-30$11.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$23.30M
derived: sum of 2 quarters · filed 2019-11-05
$41.19M
10-Q · filed 2019-11-05
$60.97M
derived: sum of 4 quarters · filed 2020-05-11
2019-06-30$12.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$30.15M
10-Q · filed 2019-08-07
$49.92M
derived: sum of 3 quarters · filed 2020-05-11
$61.31M
derived: sum of 4 quarters · filed 2020-05-11
2019-03-31$17.89M
10-Q · filed 2020-05-11
$37.67M
derived: sum of 2 quarters · filed 2020-05-11
$49.06M
derived: sum of 3 quarters · filed 2020-05-11
$62.27M
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$19.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$31.17M
derived: sum of 2 quarters · filed 2020-02-28
$44.38M
derived: sum of 3 quarters · filed 2020-02-28
$55.36M
10-K · filed 2020-02-28
$46.16M
10-K · filed 2019-03-01
2018-09-30$11.39M
10-Q · filed 2018-11-07
$24.61M
derived: sum of 2 quarters · filed 2018-11-07
$35.59M
10-Q · filed 2019-11-05
$46.47M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$13.21M
10-Q · filed 2018-08-09
$24.19M
10-Q · filed 2019-08-07
$35.07M
derived: sum of 3 quarters · filed 2020-02-28
$45.19M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$10.98M
10-Q · filed 2019-05-08
$21.86M
derived: sum of 2 quarters · filed 2020-02-28
$31.97M
derived: sum of 3 quarters · filed 2020-02-28
$45.23M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$10.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$20.99M
derived: sum of 2 quarters · filed 2020-02-28
$34.25M
derived: sum of 3 quarters · filed 2020-02-28
$43.28M
10-K · filed 2020-02-28
2017-09-30$10.12M
10-Q · filed 2018-11-07
$23.37M
derived: sum of 2 quarters · filed 2018-11-07
$32.41M
10-Q · filed 2018-11-07
$40.30M
derived: sum of 4 quarters · filed 2019-03-01
2017-06-30$13.26M
10-Q · filed 2018-08-09
$22.29M
10-Q · filed 2018-08-09
$30.19M
derived: sum of 3 quarters · filed 2019-03-01
$37.96M
derived: sum of 4 quarters · filed 2019-03-01
2017-03-31$9.03M
10-Q · filed 2018-05-10
$16.93M
derived: sum of 2 quarters · filed 2019-03-01
$24.70M
derived: sum of 3 quarters · filed 2019-03-01
$32.33M
derived: sum of 4 quarters · filed 2019-03-01
2016-12-31$7.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
$15.67M
derived: sum of 2 quarters · filed 2019-03-01
$23.29M
derived: sum of 3 quarters · filed 2019-03-01
$30.36M
10-K · filed 2019-03-01
2016-09-30$7.77M
10-Q · filed 2017-11-09
$15.39M
derived: sum of 2 quarters · filed 2017-11-09
$22.46M
10-Q · filed 2017-11-09
$29.29M
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30$7.62M
10-Q · filed 2017-08-09
$14.69M
10-Q · filed 2017-08-09
$21.52M
derived: sum of 3 quarters · filed 2018-03-01
$27.62M
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$7.07M
10-Q · filed 2017-05-09
$13.89M
derived: sum of 2 quarters · filed 2018-03-01
$20.00M
derived: sum of 3 quarters · filed 2018-03-01
$24.75M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$6.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$12.93M
derived: sum of 2 quarters · filed 2018-03-01
$17.68M
derived: sum of 3 quarters · filed 2018-03-01
$22.86M
10-K · filed 2018-03-01
2015-09-30$6.10M
10-Q · filed 2016-11-07
$10.86M
derived: sum of 2 quarters · filed 2016-11-07
$16.03M
10-Q · filed 2016-11-07
$18.49M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$4.76M
10-Q · filed 2016-08-09
$9.93M
10-Q · filed 2016-08-09
$12.39M
derived: sum of 3 quarters · filed 2017-03-01
$14.54M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$5.17M
10-Q · filed 2016-05-06
$7.63M
derived: sum of 2 quarters · filed 2017-03-01
$9.78M
derived: sum of 3 quarters · filed 2017-03-01
$12.20M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$2.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$4.61M
derived: sum of 2 quarters · filed 2017-03-01
$7.03M
derived: sum of 3 quarters · filed 2017-03-01
$9.33M
10-K · filed 2017-03-01
2014-09-30$2.15M
10-Q · filed 2015-11-09
$4.57M
derived: sum of 2 quarters · filed 2015-11-09
$6.88M
10-Q · filed 2015-11-09
$8.39M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$2.42M
10-Q · filed 2015-08-05
$4.73M
10-Q · filed 2015-08-05
$6.24M
derived: sum of 3 quarters · filed 2016-02-29
$7.78M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$2.30M
10-Q · filed 2015-05-07
$3.82M
derived: sum of 2 quarters · filed 2016-02-29
$5.35M
derived: sum of 3 quarters · filed 2016-02-29
$6.56M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$3.05M
derived: sum of 2 quarters · filed 2016-02-29
$4.26M
derived: sum of 3 quarters · filed 2016-02-29
$4.97M
10-K · filed 2016-02-29
2013-09-30$1.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$2.74M
derived: sum of 2 quarters · filed 2014-11-10
$3.46M
10-Q · filed 2014-11-10
$4.25M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$1.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
$1.92M
10-Q · filed 2014-08-06
$2.71M
derived: sum of 3 quarters · filed 2015-03-02
$3.32M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$713.00K
10-Q · filed 2014-05-13
$1.50M
derived: sum of 2 quarters · filed 2015-03-02
$2.11M
derived: sum of 3 quarters · filed 2015-03-02
2012-12-31$792.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$1.40M
derived: sum of 2 quarters · filed 2015-03-02
$2.81M
10-K · filed 2015-03-02
2012-09-30$606.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$2.02M
10-Q · filed 2013-11-06
2012-06-30$1.41M
10-Q · filed 2013-08-14
2011-12-31$2.35M
10-K · filed 2014-03-03